Abstract
The present paper shows how cinnamon extract (CE) consumption mitigates neuronal loss and memory impairment following traumatic brain injury (TBI), one of the world’s most common neurodegenerative diseases. TBI patients suffer short- and long-term behavioral, cognitive, and emotional impairments, including difficulties in concentration, memory loss, and depression. Research shows that CE application can mitigate cognitive and behavioral impairments in animal models for Alzheimer’s and Parkinson’s disease, whose pathophysiology is similar to that of TBI. This study builds on prior research by showing similar results in TBI mice models. After drinking CE for a week, mice were injured using our 70-g weight drop TBI device. For 2 weeks thereafter, the mice continued drinking CE alongside standard lab nutrition. Subsequently, the mice underwent behavioral tests to assess their memory, motor activity, and anxiety. The mice brains were harvested for immunohistochemistry staining to evaluate overall neuronal survival. Our results show that CE consumption almost completely mitigates memory impairment and decreases neuronal loss after TBI. Mice that did not consume CE demonstrated impaired memory. Our results also show that CE consumption attenuated neuronal loss in the temporal cortex and the dentate gyrus. Mice that did not consume CE suffered a significant neuronal loss. There were no significant differences in anxiety levels and motor activity between all groups. These findings show a new therapeutic approach to improve cognitive function and decrease memory loss after TBI.
Similar content being viewed by others
References
Anderson RA, Leigh Broadhurst C, Polansky MM, Schmidt WF, Khan A, Flanagan VP, Schoene NW, Graves DJ (2004) Isolation and characterization of polyphenol type-a polymers from cinnamon with insulin-like biological activity. J Agric Food Chem 52(1):65–70
Anderson RA, Qin B, Canini F, Poulet L, Roussel AM (2013) Cinnamon counteracts the negative effects of a high fat/high fructose diet on behavior, brain insulin signaling and Alzheimer-associated changes. PLoS One 8(12):e83243
Baratz R, Rubovitch V, Frenk H, Pick CG (2010) The influence of alcohol on behavioral recovery after MTBI in mice. J Neurotrauma 27(3):555–563
Baratz R, Tweedie D, Wang JY, Rubovitch V, Luo W, Hoffer BJ, Greig NH, Pick CG (2015) Transiently lowering tumor necrosis factor-Aα synthesis ameliorates neuronal cell loss and cognitive impairments induced by minimal traumatic brain injury in mice. J Neuroinflammation 12(1):45
Belzung C, Griebel G (2001). Measuring normal and pathological anxiety-like behaviour in mice: a review. Pp. 141–49 in Behavioural Brain Research. Vol. 125
Brahmachari S, Jana A, Pahan K (2009) Sodium benzoate, a metabolite of cinnamon and a food additive, reduces microglial and astroglial inflammatory responses. J Immunol 183(9):5917–5927
Chen YF, Wang YW, Huang WS, Lee MM, Gibson Wood W, Leung YM, Tsai HY (2016) Trans-cinnamaldehyde, an essential oil in cinnamon powder, ameliorates cerebral ischemia-induced brain injury via inhibition of neuroinflammation through attenuation of INOS, COX-2 expression and NFκ-B signaling pathway. NeuroMolecular Med 18(3):322–333
Choe MC (2016) The pathophysiology of concussion. Curr Pain Headache Rep 20(6):42
Daneshvar DH, Riley DO, Nowinski CJ, McKee AC, Stern RA, Cantu RC (2011) Long-term consequences: effects on normal development profile after concussion. Phys Med Rehabil Clin N Am 22(4):683–700
Dix SL, Aggleton JP (1999) Extending the spontaneous preference test of recognition: evidence of object-location and object-context recognition. Behav Brain Res 99(2):191–200
Dugoua JJ, Seely D, Perri D, Cooley K, Forelli T, Mills E, Koren G (2007) From type 2 diabetes to antioxidant activity: a systematic review of the safety and efficacy of common and cassia cinnamon bark. Can J Physiol Pharmacol 85(9):837–847
Edut S, Rubovitch V, Schreiber S, Pick CG (2011) The intriguing effects of ecstasy (MDMA) on cognitive function in mice subjected to a minimal traumatic brain injury (MTBI). Psychopharmacology 214(4):877–889
Espejo EF (1997) Structure of the mouse behaviour on the elevated plus-maze test of anxiety. Behav Brain Res 86(1):105–112
Fleminger S, Oliver DL, Lovestone S, Rabe-Hesketh S, Giora A (2003) Head injury as a risk factor for Alzheimer’s disease: the evidence 10 years on; a partial replication. Journal of Neurology Neurosurgery and Psychiatry 74(7):857–862
Frydman-Marom A, Levin A, Farfara D, Benromano T, Scherzer-Attali R, Peled S, Vassar R, Segal D, Gazit E, Frenkel D, Ovadia M (2011) Orally administrated cinnamon extract reduces β-amyloid oligomerization and corrects cognitive impairment in Alzheimer’s disease animal models. PLoS One 6(1):e16564
Gende B, Liesel IF, Fritz R, Martin Javier E (2008) Antimicrobial activity of cinnamon (Cinnamomum Zeylanicum) essential oil and its main components against Paenibacillus larvae from argentine. Bulletin of Insectology 61(1):1–4
Goldman SM, Tanner CM, Oakes D, Bhudhikanok GS, Gupta A, William Langston J (2006) Head injury and Parkinson’s disease risk in twins. Ann Neurol 60(1):65–72
Greve MW, Zink BJ (2009) Pathophysiology of traumatic brain injury. Mt Sinai J Med 76(2):97–104
Holm L, David Cassidy J, Carroll LJ, Borg J (2005) Summary of the WHO collaborating Centre for Neurotrauma Task Force on mild traumatic brain injury. J Rehabil Med 37(3):137–141
Khan A, Safdar M, Khan MMA, Khattak KN, Anderson RA (2003) Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 26(12):3215–3218
Levin HS, Diaz-Arrastia RR (2015) Diagnosis, prognosis, and clinical management of mild traumatic brain injury. The Lancet Neurology 14(5):506–517
Lighthall JW (1988) Controlled cortical impact: a new experimental brain injury model. J Neurotrauma 5(1):1–15
Lin LC, Wang MN, Tseng TY, Sung JS, Tsai TH (2007) Pharmacokinetics of (-)-epigallocatechin-3-gallate in conscious and freely moving rats and its brain regional distribution. J Agric Food Chem 55(4):1517–1524
Maas AIR, Stocchetti N, Bullock R (2008) Moderate and severe traumatic brain injury in adults. The Lancet Neurology 7(8):728–741
Manach C, Williamson G, Morand C, Scalbert A, Rémésy C (2005). Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. The American Journal of Clinical Nutrition 81(1 Suppl)
McAllister TW (2011) Neurobiological consequences of traumatic brain injury. Dialogues Clin Neurosci 13(3):287–300
McInnes K, Friesen CL, MacKenzie DE, Westwood DA, Boe SG (2017) Mild traumatic brain injury (MTBI) and chronic cognitive impairment: a scoping review. PLoS One 12(4):e0174847
McIntosh TK, Vink R, Noble L, Yamakami I, Fernyak S, Soares H, Faden AL (1989) Traumatic brain injury in the rat: characterization of a lateral fluid-percussion model. Neuroscience 28(1):233–244
Milman A, Rosenberg A, Weizman R, Pick CG (2005) Mild traumatic brain injury induces persistent cognitive deficits and behavioral disturbances in mice. J Neurotrauma 22(9):1003–1010
Momtaz S, Hassani S, Khan F, Ziaee M (2018) Cinnamon , a promising prospect towards Alzheimer ’ s disease. Pharmacol Res 130:241–258
Moppett IK (2007) Traumatic brain injury: assessment, resuscitation and early management. Br J Anaesth 99(1):18–31
Mustafa AG, Al-Shboul OA (2013) Pathophysiology of traumatic brain injury. Neurosciences 18(3):222–234
Ouattara B, Simard RE, Holley RA, Piette GJP, Bégin A (1997) Antibacterial activity of selected fatty acids and essential oils against six meat spoilage organisms. Int J Food Microbiol 37(2–3):155–162
Peterson DW, George RC, Scaramozzino F, Lapointe NE, Anderson RA, Graves DJ, Lew J (2009) Cinnamon extract inhibits tau aggregation associated with Alzheimer’s disease in vitro. J Alzheimers Dis 17(3):585–597
Rachmany L, Tweedie D, Rubovitch V, Yu Q-S, Li Y, Wang J-Y, Pick CG, Greig NH (2013) “Cognitive impairments accompanying rodent mild traumatic brain injury involve P53-dependent neuronal cell death and are ameliorated by the tetrahydrobenzothiazole PFT-α” edited by B. K. Harvey. PLoS ONE 8(11):e79837
Rao PV, and Gan SH (2014). Cinnamon: a multifaceted medicinal plant. Evidence-Based Complementary and Alternative Medicine : ECAM 2014
Russell RM, Paiva SAR (1999) β-Carotene and other carotenoids as antioxidants. J Am Coll Nutr 18(5):426–433
Schaffer S, Halliwell B (2012) Do polyphenols enter the brain and does it matter? Some theoretical and practical considerations. Genes and Nutrition 7(2):99–109
Shaltiel-Karyo R, Davidi D, Frenkel-Pinter M, Ovadia M, Segal D, Gazit E (2012) Differential inhibition of α-synuclein oligomeric and fibrillar assembly in Parkinson’s disease model by cinnamon extract. Biochim Biophys Acta Gen Subj 1820(10):1628–1635
Simiand J, Keane PE, Morre M (1984) The staircase test in mice: a simple and efficient procedure for primary screening of anxiolytic agents. Psychopharmacology 84(1):48–53
Slemmer JE, Zhu C, Landshamer S, Trabold R, Grohm J, Ardeshiri A, Wagner E, Sweeney MI, Blomgren K, Culmsee C, Weber JT, Plesnila N (2008) Causal role of apoptosis-inducing factor for neuronal cell death following traumatic brain injury. Am J Pathol 173(6):1795–1805
Yulug B, Kilic E, Altunay S, Ersavas C, Orhan C, Dalay A, Tuzcu M, Sahin N, Juturu V, Sahin K (2018) Cinnamon polyphenol extract exerts neuroprotective activity in traumatic brain injury in male mice. CNS Neurol Disord Drug Targets 17(6):439–447
Zohar O, Schreiber S, Getslev V, Schwartz JP, Mullins PG, Pick CG (2003) Closed-head minimal traumatic brain injury produces long-term cognitive deficits in mice. Neuroscience 118(4):949–955
Zohar O, Rubovitch V, Milman A, Schreiber S, Pick CG (2011) Behavioral consequences of minimal traumatic brain injury in mice. Acta Neurobiol Exp 71(1):36–45
Acknowledgements
This research was supported in part by the Ari and Regine Aprijaskis Fund at Tel-Aviv University and the Dr. Miriam and Sheldon G. Adelson Chair for the Biology of Addictive Diseases in Tel-Aviv University, Tel-Aviv, Israel.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The Sackler Commission on Animal Experimentation approved the trial protocol M-14-050, M-15-011, in line with the Guidelines for Animal Experimentation of the National Institutes of Health (DHEW publication 85-23, revised, 1995).
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Qubty, D., Rubovitch, V., Benromano, T. et al. Orally Administered Cinnamon Extract Attenuates Cognitive and Neuronal Deficits Following Traumatic Brain Injury. J Mol Neurosci 71, 178–186 (2021). https://doi.org/10.1007/s12031-020-01688-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-020-01688-4